Glenview Capital Management’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

Glenview Capital Management’s Portfolio ATIP.WS Stock Details ATIP.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300,000	Closed	-$198K	–	66
2021 Q3	$198K	Hold	300,000	–	–	﹤0.01%	60
2021 Q2	$681K	Buy	+300,000	New	+$674K	0.01%	65

Other funds holding ATIP.WS

FIG

Fortress Investment Group New York $531M AUM 12.95% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

SCC

Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

ICMH

Integrity Capital Management (HK) Central, Hong Kong $19.4M AUM

Glenview Capital Management's ATIP.WS Position: Q4 2021 in Review

Glenview Capital Management sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q4 2021, closing a stake of 300,000 shares — an estimated $198K sold.

Glenview Capital Management first reported a position in ATIP.WS in Q2 2021 and held it in 2 quarters. The position peaked at $681K in Q2 2021. 22 funds tracked by Wall St. Rank hold ATIP.WS as of Q4 2021.

Glenview Capital Management reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
Glenview Capital Management sold 300,000 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q4 2021, an estimated $198K.
Glenview Capital Management first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 2 quarters.
Glenview Capital Management's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $681K in Q2 2021.
22 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q4 2021.

Based on Glenview Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.